Contact: Morwenna Grills
University of Manchester
Caption: This image shows cancerous B cells that have been treated with rituximab. The protein CD20 (shown in green) has been drawn to the side of the cells. When the Natural Killer white blood cells approach they will stand an 80 percent chance of killing the cell if they latch on to the side where the protein has collected.
Usage Restrictions: None
Related news release: Video reveals cancer cells' Achilles' heel